Ad
AGEN Short Information Agenus Inc.
home / stock / agen / agen short
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 12,020,372 |
| Total Actual Volume | 85,332,605 |
| Short Trends | |
|---|---|
| Cover Days | 0 |
| Short Days | 20 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 601,019 |
| Average Short Percentage | 63.88% |
Is there a AGEN Short Squeeze or Breakout about to happen?
See the AGEN Short Analysis for free Sign up or Login
Powered by Squeeze Report
AGEN Twenty Trading Day's Volume to Short Volume Chart
AGEN Twenty Trading Day Price Chart
AGEN Short Data Results Days
| Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 2022-09-29 | 2.15 | 2.06 | 2.19 | 2.035 | 4,746,192 | 546,650 | 68.4246 |
| 2022-09-28 | 2.09 | 2.2 | 2.225 | 2.07 | 6,953,328 | 1,509,739 | 79.7578 |
| 2022-09-27 | 2.04 | 2.04 | 2.085 | 1.995 | 5,176,855 | 434,072 | 63.3690 |
| 2022-09-26 | 2.11 | 1.96 | 2.195 | 1.95 | 3,844,967 | 548,480 | 52.7287 |
| 2022-09-23 | 2.22 | 2.13 | 2.22 | 2.1 | 6,294,666 | 952,945 | 73.5768 |
| 2022-09-22 | 2.29 | 2.24 | 2.29 | 2.18 | 4,125,405 | 642,864 | 71.1197 |
| 2022-09-21 | 2.33 | 2.26 | 2.385 | 2.25 | 2,954,003 | 337,750 | 60.4063 |
| 2022-09-20 | 2.27 | 2.29 | 2.36 | 2.25 | 1,931,975 | 267,976 | 66.9605 |
| 2022-09-19 | 2.3 | 2.31 | 2.3255 | 2.25 | 3,240,928 | 323,008 | 50.3596 |
| 2022-09-16 | 2.49 | 2.34 | 2.495 | 2.32 | 8,620,082 | 587,916 | 57.9174 |
| 2022-09-15 | 2.41 | 2.52 | 2.54 | 2.405 | 2,524,317 | 349,222 | 57.1184 |
| 2022-09-14 | 2.47 | 2.44 | 2.49 | 2.4 | 4,024,838 | 618,094 | 64.2903 |
| 2022-09-13 | 2.6 | 2.49 | 2.64 | 2.43 | 5,476,943 | 859,862 | 63.4410 |
| 2022-09-12 | 2.7 | 2.7 | 2.71 | 2.62 | 2,290,283 | 453,617 | 69.4074 |
| 2022-09-09 | 2.62 | 2.69 | 2.715 | 2.5535 | 3,048,378 | 558,183 | 67.2269 |
| 2022-09-08 | 2.5 | 2.62 | 2.66 | 2.485 | 3,671,191 | 496,099 | 64.3016 |
| 2022-09-07 | 2.4 | 2.54 | 2.54 | 2.4 | 3,759,700 | 430,174 | 63.7038 |
| 2022-09-06 | 2.58 | 2.42 | 2.58 | 2.41 | 3,712,876 | 554,743 | 66.0810 |
| 2022-09-01 | 2.68 | 2.73 | 2.75 | 2.61 | 4,943,113 | 952,708 | 63.3268 |
| 2022-08-31 | 2.7 | 2.7 | 2.79 | 2.68 | 3,992,565 | 596,270 | 54.1535 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Patricia Carlos named Chief Regulatory, Quality, and Safety Officer Todd Yancey, MD named Senior Global Clinical Development, Medical Affairs and Commercial Advisor LEXINGTON, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an ext...
-
Phase 2 ACTIVATE trials to advance globally in metastatic patients who have progressed on available therapies Botensilimab, alone and in combination with balstilimab (PD-1), has demonstrated robust clinical activity in nine treatment-resistant tumor types, including microsatel...
-
Image source: The Motley Fool. Agenus (NASDAQ: AGEN) Q2 2022 Earnings Call Aug 09, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Agenus (AGEN) Q2 2022 Earnings Call Transcript